Black Diamond raises $85M series C, shoots to enter clinic next half

As Black Diamond prepares to bring its first cancer candidate to the clinic and build out its tumor-agnostic pipeline, the company has raised $85 million in a oversubscribed series C led by

Read the full 320 word article

User Sign In